U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                     FORM 4
                  Statement of Changes in Beneficial Ownership

                       Filed   pursuant  to  Section  16(a)  of  the  Securities
                 Exchange  Act of  1934,  Section  17(a) of the  Public  Utility
                 Holding  Company Act of 1935 or Section 30(f) of the Investment
                 Company Act of 1940


___      Check this box if no longer subject to Section 16.  Form 4 or Form 5
          obligations may continue.  See Instructions 1(b).

1.       Name and Address of Reporting Person

         Patrick Waddy
         C/o Dominion Biologicals
         5 Isnor Drive
         Dartmouth, NS  B3B  1M1 Canada

2.       Issuer Name and Ticker or Trading Symbol

         Immucor, Inc./BLUD

3.       IRS or Social Security Number of Reporting Person (Voluntary)

         NA

4.       Statement for Month/Year

         12/00

5.       If Amendment, Date of Original (Month/Year)

         NA

6.       Relationship of Reporting Person to Issuer (check all applicable)

                  Director
         X        Officer (give title below)
                  10% Owner
                  Other (specify below)

         President of Dominion Biologicals and European Finance Director

TABLE I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.       Title of Security   (Instr.3)

         Common Stock, $ .10 par value

2.       Transaction Date (Month/Day/Year)


<PAGE>



         a)  12/22/00
         b)  12/26/00
         c)  12/26/00


3.       Transaction Code (Instr. 8)
         Code
         P

4.       Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)

                Amount        (A) or (D)                     Price

            a)     1,000           A                    $3.6250 per share
            b)     5,000           A                    $3.4370 per share
            c)     5,000           A                    $3.6250 per share


5.       Amount of Securities                    6.  Ownership Form:
         Beneficially Owned at                       Direct (D) or Indirect (I)
         End of Month                                    (Instr. 4)
         (Instr. 3 and 4)

               20,000 (as previously reported)              D
               11,000                                       D
               ------
               31,000  Total

7.       Nature of Indirect
         Beneficial Ownership
            (Instr. 4)

               NA
               NA

TABLE II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
          (e.g., puts, calls, warrants, options, convertible  securities)


1.       Title of Derivative Security (Instr. 3)

         NA

2.       Conversion or Exercise Price of Derivative Security

         NA

3.       Transaction Date (Month/Day/Year)

         NA

4.       Transaction Code (Instr. 8)

         NA

5.       Number of Derivative Securities Acquired (A) or Disposed of (D)
          (Instr. 3, 4 and 5)

         Options as previously reported
         (A)                        (D)
         NA                         NA

6.       Date Exercisable and Expiration Date (Month/Day/Year)

         Date Exercisable           Expiration Date
         NA                                 NA

7.       Title and Amount of Underlying Securities (Instr. 3 and 4)

         Title                                       Amount or Number of Shares
         NA                                          NA

8.       Price of Derivative Security (Instr. 5)

         NA

9.       Number of Derivative Securities Beneficially Owned at End of Month
          (Instr. 4)

         30,500  (as previously reported)

10.      Ownership Form of Derivative Security:  Direct (D) or Indirect (I)
          (Instr. 4)

         D

11.      Nature of Indirect Beneficial Ownership (Instr. 4)

         NA

Explanation of Responses:

NA


/s/ Patrick Waddy, by Steven C. Ramsey as Power of Attorney
-----------------------------------------------------------
Signature of Reporting Person

02/09/01
---------
Date
[{"type": "4", "sequence": "1", "filename": "0001.txt", "description": "FORM 4 FOR OFFICER", "secsgml_size_bytes": 4204}]
U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                     FORM 4
                  Statement of Changes in Beneficial Ownership

                       Filed   pursuant  to  Section  16(a)  of  the  Securities
                 Exchange  Act of  1934,  Section  17(a) of the  Public  Utility
                 Holding  Company Act of 1935 or Section 30(f) of the Investment
                 Company Act of 1940

___      Check this box if no longer subject to Section 16.  Form 4 or Form 5
          obligations may continue.  See Instructions 1(b).

1.       Name and Address of Reporting Person

         Patrick Waddy
         C/o Dominion Biologicals
         5 Isnor Drive
         Dartmouth, NS  B3B  1M1 Canada

2.       Issuer Name and Ticker or Trading Symbol

         Immucor, Inc./BLUD

3.       IRS or Social Security Number of Reporting Person (Voluntary)

         NA

4.       Statement for Month/Year

         12/00

5.       If Amendment, Date of Original (Month/Year)

         NA

6.       Relationship of Reporting Person to Issuer (check all applicable)

                  Director
         X        Officer (give title below)
                  10% Owner
                  Other (specify below)

         President of Dominion Biologicals and European Finance Director

TABLE I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.       Title of Security   (Instr.3)

         Common Stock, $ .10 par value

2.       Transaction Date (Month/Day/Year)
a)  12/22/00
         b)  12/26/00
         c)  12/26/00

3.       Transaction Code (Instr. 8)
         Code
         P

4.       Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)

                Amount        (A) or (D)                     Price

            a)     1,000           A                    $3.6250 per share
            b)     5,000           A                    $3.4370 per share
            c)     5,000           A                    $3.6250 per share

5.       Amount of Securities                    6.  Ownership Form:
         Beneficially Owned at                       Direct (D) or Indirect (I)
         End of Month                                    (Instr. 4)
         (Instr. 3 and 4)

               20,000 (as previously reported)              D
               11,000                                       D
               ------
               31,000  Total

7.       Nature of Indirect
         Beneficial Ownership
            (Instr. 4)

               NA
               NA

TABLE II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
          (e.g., puts, calls, warrants, options, convertible  securities)

1.       Title of Derivative Security (Instr. 3)

         NA

2.       Conversion or Exercise Price of Derivative Security

         NA

3.       Transaction Date (Month/Day/Year)

         NA

4.       Transaction Code (Instr. 8)

         NA

5.       Number of Derivative Securities Acquired (A) or Disposed of (D)
          (Instr. 3, 4 and 5)

         Options as previously reported
         (A)                        (D)
         NA                         NA

6.       Date Exercisable and Expiration Date (Month/Day/Year)

         Date Exercisable           Expiration Date
         NA                                 NA

7.       Title and Amount of Underlying Securities (Instr. 3 and 4)

         Title                                       Amount or Number of Shares
         NA                                          NA

8.       Price of Derivative Security (Instr. 5)

         NA

9.       Number of Derivative Securities Beneficially Owned at End of Month
          (Instr. 4)

         30,500  (as previously reported)

10.      Ownership Form of Derivative Security:  Direct (D) or Indirect (I)
          (Instr. 4)

         D

11.      Nature of Indirect Beneficial Ownership (Instr. 4)

         NA

Explanation of Responses:

NA

/s/ Patrick Waddy, by Steven C. Ramsey as Power of Attorney
-----------------------------------------------------------
Signature of Reporting Person

02/09/01
---------
Date